Treatment of Advanced Non-Small-Cell Lung Cancer: From Chemotherapy to Chemoimmunotherapy

被引：14
|
作者：
Pirker, Robert [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 09期
关键词：
DOCETAXEL; NIVOLUMAB; PEMBROLIZUMAB; PHASE-3;
D O I：
10.1200/JOP.18.00474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：537 / +
页数：3
相关论文
共 50 条
  • [1] CHEMOTHERAPY IN TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER
    SCULIER, JP
    [J]. REVUE DES MALADIES RESPIRATOIRES, 1993, 10 (04) : 287 - 289
  • [2] Resistance to chemoimmunotherapy in non-small-cell lung cancer
    Hochmair, Maximilian Johannes
    [J]. CANCER DRUG RESISTANCE, 2020, 3 (03) : 445 - 453
  • [3] CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    SPLINTER, TAW
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (10) : 1093 - 1099
  • [4] CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER
    WALLING, J
    [J]. RESPIRATORY MEDICINE, 1994, 88 (09) : 649 - 657
  • [5] Optimal chemotherapy in advanced non-small-cell lung cancer
    Pohl, G
    Malayeri, R
    Doweik, L
    Minar, W
    Pirker, R
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 125 - 133
  • [6] Maintenance chemotherapy in advanced non-small-cell lung cancer
    Jassem, Jacek
    [J]. LANCET ONCOLOGY, 2012, 13 (03): : 217 - 218
  • [7] Advances in chemotherapy in advanced non-small-cell lung cancer
    Maione, Paolo
    Rossi, Antonio
    Sacco, Paola Claudia
    Bareschino, Maria Anna
    Schettino, Clorinda
    Gridelli, Cesare
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (18) : 2997 - 3007
  • [8] Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
    Rossi, Antonio
    La Salvia, Anna
    Di Maio, Massimo
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (03) : 171 - 180
  • [9] Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer
    Recchia, F
    Sica, G
    De Filippis, S
    Rea, S
    Frati, L
    [J]. ANTICANCER RESEARCH, 1997, 17 (5B) : 3761 - 3765
  • [10] Chemoimmunotherapy for stage IV non-small-cell lung cancer
    Uprety, Dipesh
    [J]. LANCET ONCOLOGY, 2019, 20 (09): : E466 - E466
12345